Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Biologically Active Products from Nature is Scopus-indexed (Q2, CiteScore 2.3), WoS ESCI. It is covered by India's One Nation One Subscription scheme for reading access. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 2231-1866Verify ISSN ↗2231-1874Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Agricultural and Biological Sciences (miscellaneous) | 119 / 253 | 53rd | Q2 |
| Complementary and Alternative Medicine | 57 / 115 | 50th | Q2 |
| Plant Science | 284 / 541 | 47th | Q3 |
| Pharmacology | 236 / 328 | 28th | Q3 |
| Drug Discovery | 125 / 161 | 22nd | Q4 |
| Toxicology | 102 / 131 | 22nd | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2011–present, best quartile Q2, CiteScore 2.3.
Journal of Biologically Active Products from Nature is Q2 in Agricultural and Biological Sciences (miscellaneous) (rank 119 of 253), Q2 in Complementary and Alternative Medicine (rank 57 of 115) and Q3 in Plant Science (rank 284 of 541), by CiteScore 2025. It is ranked in 6 subject areas in all.
Journal of Biologically Active Products from Nature is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.3, which places it in quartile Q2 at the 53rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.274, quartile Q3, with an H-index of 23.
Journal of Biologically Active Products from Nature is published by Taylor and Francis Ltd. Its print ISSN is 2231-1866 and its online ISSN is 2231-1874.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Journal of Biologically Active Products from Nature has an h-index of 22 and a 2-year mean of 1.21 citations per paper (OpenAlex). Its Scopus CiteScore is 2.3, quartile Q2. On 2-year citations it ranks #120 of 243 Scopus journals in Agricultural and Biological Sciences (miscellaneous).
Journal of Biologically Active Products from Nature published 41 papers in 2025; its busiest recent year was 2019 with 41. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2024–2026), authors are most often from India (28.4%), Vietnam (7.7%) and Thailand (6.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.